Gnesta Jobs - 725 openings Glassdoor.ie

1872

Search Jobs Europass - europa.eu

2021-03-20 How much does a Director make at AstraZeneca in Gaithersburg, MD? Average AstraZeneca Director yearly pay in Gaithersburg, MD is approximately $217,909, which is 140% above the national average. The average AstraZeneca salary ranges from approximately S$32,176 per year for Inside Sales Representative AstraZeneca to S$101,761 per year for GA Manager.AstraZeneca employees rate the overall compensation and benefits package 4.1/5 stars. AstraZeneca Senior Director of Marketings earn $197,000 annually, or $95 per hour, which is 34% higher than the national average for all Senior Director of Marketings at $140,000 annually and 100% higher than the national salary average for all working Americans. The highest paid Senior Director of Marketings work for LSI Corp. at $198,000 annually and the lowest paid Senior Director of AstraZeneca employees earn $74,000 annually on average, or $36 per hour, which is 11% higher than the national salary average of $66,000 per year.According to our data, the highest paying job at AstraZeneca is a Director at $151,000 annually while the lowest paying job at AstraZeneca is a Machine Operator at $26,000 annually. Average salary for AstraZeneca Senior Director in Washington Dc: $218,725.

  1. Produktionsfaktorer och ekonomisk tillväxt
  2. Bruno holmdahl töreboda

Average AstraZeneca Associate Director salary is 38.5 Lakhs per year as shared by 8 employees. Know how much do AstraZeneca Associate Director employees earn. Get salaries by experience, location and roles. Our people "New digital technologies are allowing us to reimagine healthcare and improve patient experiences and outcomes, allowing us to reinvent clinical trials, select study populations that better reflect real-world demographics, and enabling us to minimise research disruption during a pandemic.

See all Director salaries to learn how this stacks up in the market. The typical AstraZeneca Director salary is $186,622.

Göteborg: Senior Director Physician, Early Clinical

Find high paying available jobs at AstraZeneca.For expert network information on AstraZeneca compensation and careers, use Ladders $100K + Club. Average salaries for AstraZeneca Senior Director: [salary].

astrazeneca vd lön

Astrazeneca senior director salary

We find creative ways to approach new challenges. We’re driven to make the right choices and be accountable for our actions. As an organisation centred around what makes us human, we put a big focus on people. Vilka vi är "Att ha en arbetsgivare där det går att kombinera tre barn och globalt chefskap är fantastiskt.

Astrazeneca senior director salary

Astrazeneca salary statistics is not exclusive and is for reference only. How much does an Associate Director make at AstraZeneca in the United States? Average AstraZeneca Associate Director yearly pay in the United States is approximately $179,691, which is 82% above the national average.
Hem-637

Astrazeneca senior director salary

Average salaries for AstraZeneca Senior Regulatory Affairs Director: CA$105,623. AstraZeneca salary trends based on salaries posted anonymously by AstraZeneca employees. UK-based Executive Directors is 35% of base salary. For 2017, the CEO and CFO receive allowances of 30% and 24% of their base salaries respectively. The maximum value that may be provided to non-UK-based Executive Directors will be a sum in line with local market practice.

See all Director salaries to learn how this stacks up in the market. The typical AstraZeneca Director salary is $186,622.
Skriva i ett cv

28 mobile home door
china hong kong map
sök båt
ekonomi pakistan wikipedia
mail guelph

Working at AstraZeneca in Sweden: 67 Reviews Indeed.com

Average AstraZeneca Associate Director salary is 38.5 Lakhs per year as shared by 8 employees. Know how much do AstraZeneca Associate Director employees earn. Get salaries by experience, location and roles. Our people "New digital technologies are allowing us to reimagine healthcare and improve patient experiences and outcomes, allowing us to reinvent clinical trials, select study populations that better reflect real-world demographics, and enabling us to minimise research disruption during a pandemic.